TurboHawk plaque excision system combined with drug-coated balloon for the treatment of femoral popliteal artery in-stent restenosis
10.3760/cma.j.cn113855-20190918-00555
- VernacularTitle:定向斑块旋切系统联合药物涂层球囊治疗股腘动脉支架内再狭窄
- Author:
Huan ZHANG
1
;
Luyuan NIU
;
Fuxian ZHANG
;
Xiaoyun LUO
;
Changming ZHANG
;
Yaping FENG
Author Information
1. 首都医科大学附属北京世纪坛医院血管外科 100038
- From:
Chinese Journal of General Surgery
2020;35(6):476-479
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the clinical effect of TurboHawk plaque excision system combined with drug-coated balloon in the treatment of femoral popliteal artery in-stent restenosis.Methods:The clinical and follow-up data of 13 patients with femoral popliteal artery in-stent restenosis were retrospectively analyzed, ankle-brachial index (ABI) and lower extremity artery CTA before and after surgery were recorded.Results:Surgery was successful in all the 13 patients.There was perioperative death, no major complications. One patient underwent salvage stent implantation due to residual stenosis of more than 30% in the proximal end of the stent after rotary cutting and expansion . The average postoperative ABI was (0.90±0.08), significantly higher than that before the operation ( P<0.05). All patients were followed-up for mean 16.4 months, One patient died of acute heart failure after 13 months, one of the lower extremity vascular CTA confirmed in-stent restenosis was treated by drug-coated balloon. The primary patency rate was 84.6% at one year. Conclusion:The mid-term results of directional atherectomy system combined with drug-coated balloon in the treatment of femoral artery in-stent restenosis is satisfactory.
